Literature DB >> 11926419

The prevalence and association of neck (coat-hanger) pain and orthostatic (postural) hypotension in human spinal cord injury.

P Cariga1, S Ahmed, C J Mathias, B P Gardner.   

Abstract

OBJECTIVE: To investigate the prevalence of orthostatic (postural) hypotension (OH) and neck pain in a 'coat-hanger' occipito-cervical distribution in subjects with spinal cord injury (SCI), and their association.
METHOD: Blood pressure was measured during head-up tilt to 60 degrees (to determine OH) and neck pain was assessed in 28 subjects with SCI (cervical, thoracic and lumbar level) with McGill Pain Questionnaire, visual analogue scale for pain intensity and Orthostatic Intolerance Symptoms Questionnaire for pain frequency.
RESULTS: Neck pain was reported by 53.6% of subjects. Orthostatic hypotension was present in 57.1% of subjects. Neck pain was reported by 75% of subjects with OH and 25% of subjects without OH (P<0.03, Chi-square). Features of such pain included positive correlation to upright posture and exercise, and relief when lying flat.
CONCLUSION: There is a high prevalence of neck pain and OH in SCI, with a positive association similar to that reported in primary autonomic failure with OH.

Entities:  

Mesh:

Year:  2002        PMID: 11926419     DOI: 10.1038/sj.sc.3101259

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  10 in total

1.  Improvements in orthostatic instability with stand locomotor training in individuals with spinal cord injury.

Authors:  Susan J Harkema; Christie K Ferreira; Rubia J van den Brand; Andrei V Krassioukov
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

2.  Relationships between physiological responses and presyncope symptoms during tilting up in patients with spinal cord injury.

Authors:  David S Liu; Walter H Chang; Alice M K Wong; Shih-Ching Chen; Kang-Ping Lin; Chien-Hung Lai
Journal:  Med Biol Eng Comput       Date:  2008-05-01       Impact factor: 2.602

3.  Lessons learned from the pilot study of an orthostatic hypotension intervention in the subacute phase following spinal cord injury.

Authors:  Bastien Moineau; Andrea Brown; Louise Brisbois; Vera Zivanovic; Masae Miyatani; Naaz Kapadia; Jane T C Hsieh; Milos R Popovic
Journal:  J Spinal Cord Med       Date:  2019-10       Impact factor: 1.985

4.  What is the incidence and severity of dysphagia after anterior cervical surgery?

Authors:  Jeffrey A Rihn; Justin Kane; Todd J Albert; Alexander R Vaccaro; Alan S Hilibrand
Journal:  Clin Orthop Relat Res       Date:  2011-03       Impact factor: 4.176

5.  Orthodeoxia syndrome: a rare complication of ASD in spinal cord injury.

Authors:  H Magimairaj; R Hariharan; P Thumbikat
Journal:  Spinal Cord Ser Cases       Date:  2015-07-09

6.  Secondary adrenal insufficiency after glucocorticosteroid administration in acute spinal cord injury: a case report.

Authors:  Huiqing Yang; Michelle Trbovich; Jeffrey Harrow
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

Review 7.  A systematic review of the management of orthostatic hypotension after spinal cord injury.

Authors:  Andrei Krassioukov; Janice J Eng; Darren E Warburton; Robert Teasell
Journal:  Arch Phys Med Rehabil       Date:  2009-05       Impact factor: 3.966

Review 8.  Cardiovascular Physiology and Responses to Sexual Activity in Individuals Living with Spinal Cord Injury.

Authors:  Ross Davidson; Aaron Phillips
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

9.  Impact of tetraplegia vs. paraplegia on venoarteriolar, myogenic and maximal cutaneous vasodilation responses of the microvasculature: Implications for cardiovascular disease.

Authors:  Michelle Trbovich; Yubo Wu; Wouter Koek; Joan Zhao; Dean Kellogg
Journal:  J Spinal Cord Med       Date:  2020-06-04       Impact factor: 1.985

Review 10.  Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.

Authors:  Sabine Eschlböck; Gregor Wenning; Alessandra Fanciulli
Journal:  J Neural Transm (Vienna)       Date:  2017-10-22       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.